SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

[July 04, 2014]

Research and Markets: PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/22vwnt/pharmasphere) has announced the addition of the "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market" report to their offering.

Our report, "PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market", provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity and trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as India - providing in-depth analysis of these markets' regulatory framework, key domestic players and their biosimilar pipelines, and strategic outlook


Key Questions Answered

  • What are the drivers of the global biosimilars industry?
  • Who are the top players involved in the development of biosimilars in the developed markets of Europe and the US, as well as in emerging markets, including India and China?
  • What are the major barriers to entry into the biosimilars industry?
  • What specific strategies are companies utilizing to combat some of the challenges currently facing the development of the global biosimilars industry?
  • What is the current state of biosimilars regulation in the EU, US, Japan, India, China, and South Korea?

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Market Overview

4 Biosimilar Deals Trends

5 Biosimilars Regulation

6 Biosimilars in the US

7 Biosimilars in Europe

8 Biosimilars in Japan

9 Biosimilars in India

10 Biosimilars in South Korea

11 Biosimilars in China

12 Case Study: Teva Pharmaceutical Industries

13 Strategic Outlook

14 Appendix

Companies Mentioned:

  • Hospira
  • Actavis
  • Pfizer
  • Sandoz
  • Stada Arzneimittel
  • Gedeon Richter
  • Kyowa Hakko Kirin Co. Ltd
  • JCR Pharmaceuticals
  • Biocon
  • Dr. Reddy's Laboratories
  • Ranbaxy Laboratories
  • Reliance Life Sciences
  • Cipla
  • Celltrion
  • Hanwha Chemical
  • Samsung (News - Alert) Bioepis
  • LG Life Sciences
  • 3SBio
  • Shandong Kexing Bioproducts

For more information visit http://www.researchandmarkets.com/research/22vwnt/pharmasphere


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy